1. Characterization of Novel Oral Splicing Modulator, H3B-8800, Identifies the Mechanistic Basis for its Preferential Lethality Towards Spliceosome-Mutant Myeloid Malignancy Models. (April 2017) Authors: Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Csibi, A.; Fekkes, P.; Klimek, V.; Kumar, P.; Lee, S.C.W.; Padron, E.; Pazolli, E.; Goldberg, J.; Sahmoud, T.; Taylor, J.; Warmuth, M.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗